Live Breaking News & Updates on Biogen Company Cambridge|Page 1

Stay updated with breaking news from Biogen company cambridge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr. David C. Fabrey: Column on Aduhelm, Alzheimers drug

Aduhelm, newly approved by the Food and Drug Administration as a treatment for Alzheimer s disease, is mired in controversy because of inconclusive results and its high cost. ....

United States , United Kingdom , Davidc Fabrey , Brad Wenstrup , Advisory Committee For Peripheral , Biogen Company , American Academy Of Neurology , Biogen Company Cambridge , Drug Administration , Controversial Alzheimer , American Academy , Advisory Committee , Central Nervous System Drugs ,